Neuroimaging in infants with prenatal opioid exposure: Current evidence, recent developments and targets for future research.

Prenatal opioid exposure (POE) has shown to be a risk factor for adverse long-term cognitive and behavioral outcomes in offspring. However, the neural mechanisms of these outcomes remain poorly understood. While preclinical and human studies suggest that these outcomes may be due to opioid-mediated changes in the fetal and early postnatal brain, other maternal, social, and environmental factors are also shown to play a role. Recent neuroimaging studies reveal brain alterations in children with POE. Early neuroimaging and novel methodology could provide an in vivo mechanistic understanding of opioid mediated alterations in developing brain. However, this is an area of ongoing research. In this review we explore recent imaging developments in POE, with emphasis on the neonatal and infant brain, and highlight some of the challenges of imaging the developing brain in this population. We also highlight evidence from animal models and imaging in older children and youth to understand areas where future research may be targeted in infants with POE.

Distribution and correlation of pancreatic gland size and duct diameters on MRCP in patients without evidence of pancreatic disease.

PURPOSE: To use MRCP to investigate age-related changes and gender differences of the pancreas and to correlate pancreatic gland size and duct diameter. METHODS: In this institutional review, board-approved, HIPAA-compliant study, 280 patients (age 20-88 years) without a history of pancreatic or liver disease who had undergone MRI/MRCP from 2004 to 2015 were identified. The anteroposterior size and main duct diameter of the pancreatic head, body, and tail were measured. The pancreatic gland and duct sizes were compared between genders, and among seven age subgroups (20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80-89). RESULTS: The pancreatic head and body were significantly larger in males than females (head, p < 0.01; body, p = 0.03), while the tail and the duct diameters of the pancreatic head, body, and tail showed no gender difference. As the age of male participants increased, there was an associated increase in size of the pancreatic gland initially (largest at age 50-59 (body) and 60-69 (head)), followed by subsequent decline in size thereafter. Additionally, the pancreatic duct diameter was found to increase gradually. In females, the size of the pancreatic gland decreased, while the diameter of the pancreatic duct increased with age. Moderate positive correlation for gland size and strong positive correlation for duct diameter among different pancreatic regions were found. Weak negative correlation was found between gland size and duct diameter. CONCLUSIONS: There are gender differences in the gland size of the pancreatic head and body. The pancreatic gland size increases until the sixth decade in males, with a more continuous decrease in gland size with age in females. Both males and females demonstrate a marked decrease in gland size after the eighth decade. The duct diameter increases with age in both males and females.

Evaluation of a new phosphor plate technology for neonatal portable chest radiographs.

RATIONALE AND OBJECTIVES: The aim of this study was to evaluate a new thick-needle phosphor plate for computed radiography. MATERIALS AND METHODS: Two studies were performed. Patients acted as their own controls. In the first study, old powder and new needle phosphor plate technologies were compared. Twenty infants were identified who had undergone chest x-rays with both systems within 3 days of each other. Exposure factors were constant. In the second study, standard and reduced exposure techniques (tube current-time product reduced by 20%) using the needle phosphor technology were compared. Twenty babies who had been imaged with both standard and reduced exposures within 3 days of each other were evaluated. RESULTS: There was a significant preference for images obtained with the new needle phosphor technology compared with the older powder technology (P < .01). Using the new needle phosphor plates, a dose reduction of 20% could be achieved without a significant detectable difference between the high-dose and low-dose images (P < .19). CONCLUSIONS: For the study comparing old and new phosphor plate technology at fixed exposure, images were better with the new technology. Using the new plate technology, dose can be decreased by ≥20%.

Tetralogy of fallot: a possible etiology for narrowing of the right pulmonary artery.

RATIONALE AND OBJECTIVES: Patients with tetralogy of Fallot have right ventricular outflow and pulmonary valve stenosis. They may also have more distal peripheral pulmonary artery stenoses. Peripheral stenosis is believed to be part of the spectrum of the genetic manifestation of tetralogy. Our hypothesis was that narrowing of the right pulmonary artery may be due to compression from the adjacent dilated ascending aorta. MATERIALS AND METHODS: We identified 27 patients with tetralogy of Fallot who underwent magnetic resonance imaging scanning postoperatively, most often for evaluation of pulmonary valve stenosis and regurgitation. On the axial image at the level of the right pulmonary artery, we measured the transverse diameters of the ascending and descending aorta, and the minimum and maximum right pulmonary artery diameters. RESULTS: There was a significant correlation between the ratios of the ascending:descending aorta diameters and the maximum:minimum right pulmonary artery diameters. Thus, increasing ascending aorta size is associated with decreasing size of the adjacent right pulmonary artery. CONCLUSIONS: In our patient population with tetralogy of Fallot, right pulmonary artery narrowing is at least partly because of compression from the adjacent enlarged ascending aorta.